葛根素防治骨质疏松症的分子机制研究进展
Research progress on the molecular mechanism of puerarin in preventing and treating osteoporosis
  
DOI:10.3969/j.issn.1006-7108.2025.12.023
中文关键词:  葛根素  骨质疏松症  作用机制  研究进展
英文关键词:Puerarin  Osteoporosis  Action mechanism  Research progress
基金项目:甘肃省科技计划项目(联合科研基金)(23JRRA1529);兰州市科技计划项目(2025-2-197);兰州市人才创新创业项目(2023-2-20)
作者单位
安国尧1 元宝华2,贾潇1,刘晖1,靳博1,李百通1,南学彦1,尤从新1,孔令俊1,赵军1* 1甘肃省中医院,甘肃省 兰州市 7300502甘肃中医药大学,甘肃省 兰州市 730030 
摘要点击次数: 2
全文下载次数: 0
中文摘要:
      既往研究表明葛根素具有显著的抗骨质疏松作用,其涉及的分子机制繁复且过程中多有交互,因此本文通过检索CNKI、WANFANG DATE、中华医学期刊全文数据库、Web of Science、Pub Med数据库最近10年关于葛根素防治骨质疏松症的文献报道,对其中涉及的分子机制进行归纳总结,以期为葛根素在未来临床中的应用提供新的思路和方向。葛根素发挥抗骨质疏松的作用机制主要有Wnt/β-catenin、PI3K/AKT、NF-κB、OPG/?RANKL/RANK、ERK1/2信号通路及BMP-2蛋白、FoxO1蛋白,除此之外还包括葛根素发挥雌激素样作用、调控细胞自噬和肠道菌群等过程,同时少量文献报道葛根素还涉及Nrf2/HO-1、p38 MAPK、ON、cAMP/PKA、SLC7A11/GPX4、JAK2/STAT3信号通路,因此葛根素通过调控上述分子机制过程抑制破骨细胞促进成骨细胞增殖与成熟分化,进而改善骨质疏松症状。另外新型的药物传递系统完美的解决了其生物利用率低的缺点,未来有望成为糖尿病性骨质疏松和老年绝经后骨质疏松患者抗骨质疏松治疗的新选择。
英文摘要:
      Previous studies have shown that puerarin has a significant anti-osteoporosis effect, and the molecular mechanisms involved are complex and often interactive. Therefore, by searching CNKI, WANFANG DATE, Chinese Medical Journal Full-text database, Web ofScience, Pub Med database in recent 10 years on the prevention and treatment of osteoporosis by puerarin, this paper summarized the molecular mechanisms involved. In order to provide a new idea and direction for the application of puerarin in the uncoming bed. The main mechanisms of the anti-osteoporosis effect of cararin include Wnt/β-catenin, PI3K/AKT, NF-κB, OPG/ RANKL/RANK, ERK1/2 signaling pathway, BMP-2 protein and FoxO1 protein. In addition, puerarin plays estrogen-like effects, regulates cytoautophagy and intestinal flora, and a few literatures have reported that puerarin is also involved in Nrf2/HO-1, p38 MAPK, ON, cAMP/PKA, SLC7A11/GPX4, JAK2/STAT3 signaling pathways. Therefore, puerarin can inhibit osteoclasts and promote the proliferation and maturation of osteoblasts by regulating the above molecular mechanisms, thus improving the symptoms of osteoporosis. In addition, the new drug delivery system perfectly solves the shortage of low bioavailability, and is expected to become a new choice for anti-osteoporosis treatment for diabetic osteoporosis and elderly postmenopausal osteoporosis patients in the future.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=FC9DA7BF2F842A3BAE24B54F70914FE6563B27C0E553AE7E72E63E98832F1C566E6C896A49916F0F7EC9976921F5E9547F7A17C083122F84CA6D6C19C7BEC0677AC01BBE6B6C99D950AB6D0FEEBC18A90250484DAC4E4409DE9FE0E967AEE9AFC24EB53F596673B9&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=E6A891D2134F30C0&aid=&vid=&iid=59906B3B2830C2C5&sid=A477487C019ACAC8&eid=240F2240A2877152&fileno=202512023&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="E6A891D2134F30C0"; var my_aid="";